ALZAMEND NEURO, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
ALZAMEND NEURO, INC. (ALZN) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $5.80 million as of 2026-07-31, per its 10-Q filed 2026-09-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-09-10
- 2026-07-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.80M.
- 2026-04-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $733.21K.
- 2025-04-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.97M.
- 2025-01-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.45M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-07-31 | $5.80M 10-Q · filed 2026-09-10 | |
| 2026-04-30 | $733.21K 10-K · filed 2026-07-22 | |
| 2025-04-30 | $3.97M 10-K · filed 2026-07-22 | |
| 2025-01-31 | $3.45M 10-Q · filed 2025-03-10 | |
| 2024-10-31 | $3.75M 10-Q · filed 2025-03-10 | |
| 2024-07-31 | -$1.21M 10-Q · filed 2024-12-11 | |
| 2024-04-30 | -$2.59M 10-K · filed 2026-07-22 | |
| 2024-01-31 | -$4.26M 10-Q · filed 2025-03-10 | |
| 2023-10-31 | -$2.68M 10-Q · filed 2025-03-10 | |
| 2023-07-31 | -$112.88K 10-Q · filed 2024-12-11 | $113.00K 10-Q · filed 2023-09-13 |
| 2023-04-30 | $3.05M 10-K · filed 2025-07-22 | |
| 2023-01-31 | $5.86M 10-Q · filed 2024-03-25 | |
| 2022-10-31 | $8.79M 10-Q · filed 2024-03-25 | |
| 2022-04-30 | $13.35M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |